BCTX
Briacell Therapeutics
BCTX
BCTX
25 hedge funds and large institutions have $379K invested in Briacell Therapeutics in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
30% less capital invested
Capital invested by funds: $538K → $379K (-$159K)
Holders
25
Holding in Top 10
–
Calls
$90K
Puts
$3K
Top Buyers
| 1 | +$31.6K | |
| 2 | +$27K | |
| 3 | +$22K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$20.7K |
| 5 |
Vontobel Holding
Zurich,
Switzerland
|
+$17K |
Top Sellers
| 1 | -$43.4K | |
| 2 | -$32.8K | |
| 3 | -$20.1K | |
| 4 |
CWP
Concord Wealth Partners
Abingdon,
Virginia
|
-$5.22K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$5K |